V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011861 | 280005422 | 1.83 | 79.7 | Palliative (P) | 2015-12-06 | 2015-12-24 | Cisplatin 7 day | N | N | 280026724 | CISPLATIN |
| 280011862 | 280005438 | 1.57 | null | Curative (C) | 2015-06-16 | 2015-06-30 | Cisplatin | 02 | Y | 280026803 | CISPLATIN |
| 280011863 | 280012104 | 1.8 | 113.6 | Neo-adjuvant (N) | 2015-01-30 | 2015-02-26 | Cisplatin | 02 | Y | 280026811 | CISPLATIN |
| 280011864 | 280005465 | null | 48.1 | Palliative (P) | 2015-08-26 | 2015-08-26 | STS Rhabdomyosarcoma RMS 2005 IVA | N | Y | 280026900 | IVA |
| 280011865 | 280005468 | 1.67 | 94.5 | Neo-adjuvant (N) | 2014-01-08 | 2014-07-28 | Ifosfamide | 02 | N | 280026902 | IFOSFAMIDE |
| 280011866 | 280008883 | 1.7 | 48.1 | Palliative (P) | 2014-10-05 | 2014-10-20 | Cetuximab + Radiotherapy Load | null | null | 280026932 | CETUXIMAB + RT |
| 280011867 | 280005529 | null | 48.1 | null | 2017-07-18 | 2017-08-09 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280027162 | RMS 2005 TRIAL |
| 280011868 | 280005567 | 0.9 | 108.4 | null | 2018-05-12 | 2018-05-21 | Cetuximab + Radiotherapy Maint | N | Y | 280027352 | CETUXIMAB + RT |
| 280011869 | 280005608 | null | null | Palliative (P) | null | 2016-05-28 | Cetuximab + Radiotherapy Maint | N | N | 280027534 | CETUXIMAB + RT |
| 280011870 | 280005626 | 1.52 | 60.5 | Curative (C) | 2017-04-03 | 2017-05-05 | CETUXIMAB + RT | N | Y | 280027573 | CETUXIMAB + RT |
| 280011871 | 280005638 | null | 58 | Adjuvant (A) | 2018-05-25 | 2018-05-27 | CARBOPLATIN + RT | N | N | 280027609 | CARBOPLATIN + RT |
| 280011872 | 280011724 | 1.86 | 57.4 | Palliative (P) | 2018-02-04 | 2019-06-26 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 280027660 | PACLITAXEL |
| 280011873 | 280005676 | null | 73.8 | Palliative (P) | 2019-05-13 | 2019-07-01 | IVA | N | N | 280027748 | IVA |
| 280011874 | 280005692 | 1.72 | 91.9 | null | 2019-09-01 | 2019-11-13 | CARBOPLATIN + RT | 02 | Y | 280027776 | CARBOPLATIN + RT |
| 280011875 | 280008987 | 1.74 | 70 | Palliative (P) | 2014-10-08 | 2015-05-20 | Doxorubicin 75mg/m2 | N | null | 280027817 | DOXORUBICIN |
| 280011876 | 280011344 | 1.62 | 86.45 | Neo-adjuvant (N) | 2019-03-05 | 2019-03-14 | DOXORUBICIN | null | null | 280027822 | DOXORUBICIN |
| 280011877 | 280005707 | 1.29 | 101 | Curative (C) | 2017-01-21 | 2017-01-21 | IVA | null | Y | 280027842 | IVA |
| 280011878 | 280008999 | 1.76 | 96.4 | Adjuvant (A) | 2016-04-18 | 2016-04-18 | CARBOPLATIN + RT | N | null | 280027858 | CARBOPLATIN + RT |
| 280011879 | 280005730 | 1.63 | 68.05 | Adjuvant (A) | 2018-07-10 | 2018-08-19 | Cetuximab + Radiotherapy Maint | N | N | 280027905 | CETUXIMAB + RT |
| 280011880 | 280005740 | 1.84 | 90 | Curative (C) | 2013-05-30 | 2013-06-14 | Ifosfamide | Y | N | 280027926 | IFOSFAMIDE |
| 280011881 | 280005758 | 1.7 | null | Adjuvant (A) | 2019-11-25 | 2020-01-16 | Oxaliplatin + Modified de Gramont | null | null | 280028006 | OXALIPLATIN + MDG |
| 280011882 | 280005782 | 1.66 | null | Palliative (P) | 2016-02-01 | 2017-02-17 | Doxorubicin + Ifosfamide | N | N | 280028075 | DOXORUBICIN + IFOSFAMIDE |
| 280011883 | 280005788 | null | 92.8 | Palliative (P) | 2013-12-09 | 2014-01-23 | DE-ESCALATE TRIAL | Y | null | 280028086 | DE-ESCALATE TRIAL |
| 280011884 | 280011354 | 1.88 | 76.4 | null | 2018-07-30 | 2018-08-13 | Doxorubicin + Ifosfamide | N | N | 280028098 | DOXORUBICIN + IFOSFAMIDE |
| 280011885 | 280005801 | 1.6 | 97 | Palliative (P) | 2015-05-05 | 2015-11-08 | Carboplatin + Etoposide IV 3 day | N | N | 280028141 | CARBOPLATIN + ETOPOSIDE |
| 280011886 | 280005804 | 1.65 | 66 | Curative (C) | 2015-07-14 | 2015-07-17 | ETOPOSIDE + IFOSFAMIDE | 02 | N | 280028146 | ETOPOSIDE + IFOSFAMIDE |
| 280011887 | 280005810 | 1.65 | 95 | Neo-adjuvant (N) | 2016-08-30 | 2016-08-30 | DE-ESCALATE TRIAL | N | N | 280028160 | DE-ESCALATE TRIAL |
| 280011888 | 280005816 | 1.71 | null | Palliative (P) | 2019-04-22 | 2019-05-02 | Cetuximab +Cisplatin + FU (Cycle 1) | Y | N | 280028182 | CETUXIMAB + CISPLATIN + FU |
| 280011889 | 280005819 | 1.59 | 142.3 | Curative (C) | 2015-02-01 | 2015-08-19 | VAC | N | N | 280028183 | CAV |
| 280011890 | 280011923 | 1.74 | 66.2 | Palliative (P) | 2018-12-27 | 2018-12-29 | Carboplatin + Paclitaxel (weekly) | 2 | N | 280028217 | CARBOPLATIN + PACLITAXEL |
| 280011891 | 280005843 | 1.85 | 73.6 | Palliative (P) | null | 2014-04-09 | DOXORUBICIN + IFOSFAMIDE | N | N | 280028259 | DOXORUBICIN + IFOSFAMIDE |
| 280011892 | 280011736 | 1.74 | 85.3 | Palliative (P) | 2016-01-29 | 2016-01-29 | Doxorubicin + Ifosfamide | 2 | N | 280028292 | DOXORUBICIN + IFOSFAMIDE |
| 280011893 | 280011365 | 1.86 | 57 | Palliative (P) | 2012-05-26 | 2014-06-14 | Cyclophosphamide oral | 02 | N | 280028302 | CYCLOPHOSPHAMIDE |
| 280011894 | 280005898 | 1.57 | 73 | Palliative (P) | 2013-12-19 | 2014-01-20 | Doxorubicin + Ifosfamide | 02 | N | 280028423 | DOXORUBICIN + IFOSFAMIDE |
| 280011895 | 280005916 | null | 81 | Palliative (P) | 2018-05-18 | 2018-05-19 | VAI (Ifos 3g/m2) | N | N | 280028455 | IRINOTECAN + MDG |
| 280011896 | 280005927 | 1.66 | 73.4 | Palliative (P) | null | 2017-01-05 | CISPLATIN + GEMCITABINE | null | null | 280028506 | CISPLATIN + GEMCITABINE |
| 280011897 | 280005942 | 1.77 | null | Palliative (P) | 2015-07-20 | 2015-09-07 | Etoposide + Ifosfamide (5 days) | N | N | 280028576 | ETOPOSIDE + IFOSFAMIDE |
| 280011898 | 280005953 | 1.84 | 48.8 | Palliative (P) | 2014-01-29 | 2014-02-02 | Cyclophosphamide oral | N | N | 280028593 | CYCLOPHOSPHAMIDE |
| 280011899 | 280005959 | 1.84 | 79.5 | Palliative (P) | 2018-04-15 | 2018-05-27 | VAI (Ifos 3g/m2) | 02 | Y | 280028610 | IRINOTECAN + TEMOZOLOMIDE |
| 280011900 | 280005983 | 1.68 | 95 | Palliative (P) | 2014-02-09 | 2014-11-30 | EW Rel rEECur Irinotecan/Temozolomide | N | N | 280028712 | VAI |
| 280011901 | 280012024 | 1.78 | 64.7 | Palliative (P) | 2016-06-25 | 2016-06-28 | CISPLATIN + FLUOROURACIL | 02 | N | 280028766 | CISPLATIN + FLUOROURACIL |
| 280011902 | 280006022 | 1.76 | 139.4 | Palliative (P) | 2015-01-30 | 2015-01-30 | EURO-EWING | null | null | 280028851 | EURO-EWING |
| 280011903 | 280006027 | 1.76 | 58.7 | Palliative (P) | 2017-09-11 | 2017-09-13 | EW Rel rEECur Irinotecan/Temozolomide | N | N | 280028860 | IRINOTECAN + TEMOZOLOMIDE |
| 280011904 | 280006032 | 1.75 | 69.3 | Palliative (P) | 2013-12-12 | 2013-12-13 | CARBOPLATIN + PACLITAXEL | N | N | 280028864 | CARBOPLATIN + PACLITAXEL |
| 280011905 | 280006039 | 1.72 | null | Palliative (P) | 2017-12-04 | 2017-12-18 | VAI (Ifos 3g/m2) | N | N | 280028918 | IRINOTECAN + MDG |
| 280011906 | 280009171 | 1.54 | 50.3 | Palliative (P) | 2017-12-01 | 2017-12-07 | CYCLOPHOSPHAMIDE | Y | N | 280028989 | CYCLOPHOSPHAMIDE |
| 280011907 | 280006057 | 1.52 | 108.5 | Curative (C) | 2016-11-03 | 2017-04-03 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280029005 | CARBOPLATIN + PACLITAXEL |
| 280011908 | 280006067 | 1.73 | 153 | Palliative (P) | 2018-02-23 | 2018-03-06 | Doxorubicin + Olaratumab | null | null | 280029015 | DOXORUBICIN + OLARATUMAB |
| 280011909 | 280006078 | null | 73.2 | Palliative (P) | 2016-09-07 | 2017-04-28 | Oxaliplatin + Modified de Gramont | N | N | 280029044 | OXALIPLATIN + MDG |
| 280011910 | 280006083 | 1.7 | 71 | Curative (C) | 2015-07-17 | 2015-07-21 | CAV | N | N | 280029057 | CAV |